Rydex Series Biotech-InvstRYOIX
13F holders, Q4 2025 (December 31)1holders
$74.83avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Rydex Series Biotech-Invst (RYOIX) in their 13F filings. The largest holder was Garton & Associates Financial Advisors LLC ($57K).
- Company
- Rydex Series Biotech-Invst
- Filed as
- RYDEX BIOTECHNOLOGY INV (Q4 2025)
- CUSIP
- 783554827
- Latest filing quarter
- Q4 2025
Total Exit/New Position Q4 2025
No earlier quarter to compare with.
Ownership 1 holders
| Garton & Associates Financial Advisors LLC | 0.03% | — | 758 | $57K |
"% of holder's portfolio" is RYOIX's weight in each manager's 13F, not the share of Rydex Series Biotech-Invst the manager owns.